A recent study published in JAMA Ophthalmology suggests that people taking Ozempic and Wegovy may face an increased risk of developing a serious eye condition that could lead to permanent vision loss. The condition, known as non-arteritic anterior ischemic optic neuropathy (NAION), affects the optic nerve and can result in sudden blindness. While the study found a higher rate of NAION in patients prescribed semaglutide (the active ingredient in Ozempic and Wegovy), more research is needed to confirm a direct link.
Experts caution that individuals with diabetes, obesity, or overweight status may already be at risk for vision problems, including NAION. Weight loss medications, like Ozempic and Wegovy, could potentially exacerbate these risks, although further studies are required to establish a definitive connection. Patients are advised to consult with their healthcare provider if they have concerns about potential side effects.
Vocabulary List:
- Ischemic /ɪˈskiː.mɪk/ (adjective): Relating to a restriction in blood supply to tissues.
- Neuropathy /nʊəˈrɒp.ə.θi/ (noun): A disease or dysfunction of one or more peripheral nerves.
- Optic /ˈɒp.tɪk/ (adjective): Relating to the eye or vision.
- Exacerbate /ɪgˈzæs.ər.beɪt/ (verb): To make a problem bad situation or negative feeling worse.
- Prescription /prɪsˈkrɪp.ʃən/ (noun): An instruction written by a medical professional for the preparation and administration of a remedy.
- Consult /kənˈsʌlt/ (verb): To seek advice or information from someone especially an expert.
How much do you know?
